# Session Summary
## Status: PARTIAL
## Reason: 1 hypothesis passed Quality Gate (CONDITIONAL PASS). Web-verified novel with high groundedness but cell-type counter-evidence.

---

## Session Details

- **Session ID**: 2026-03-18-targeted-001
- **Mode**: Targeted (from Scout session 002 unexplored target)
- **Model**: Opus 4.6
- **Pipeline version**: v5.3 (session-scoped dirs) + v5.4 (claim-level verification)
- **Target**: Ferroptosis lipid peroxidation × Bacterial quorum sensing
- **Disjointness**: DISJOINT (ferroptosis→QS direction; QS→ferroptosis already published)
- **Executed manually**: Orchestrator could not dispatch sub-agents (nesting depth limit). Pipeline phases executed directly.

## Pipeline Flow

```
Literature Scout (parametric fallback — MCP failed)
    |
    v
Cycle 1: Generate (8) → Critique (3 killed, 37.5%) → Rank (top: H8 7.6) → Evolve (4 refined)
    |
    v
Cycle 2: Generate (7 new) → Critique (3 killed, 42.9%) → Rank (top: C2-3 7.9) → Evolver SKIPPED
    |
    v
Quality Gate v5.4 (10-point rubric + per-claim verification): 1/3 CONDITIONAL PASS
```

## Pipeline Statistics

| Metric | Value |
|--------|-------|
| Total hypotheses generated | 15 (8 cycle 1 + 7 cycle 2) |
| Killed by Critic | 6 (40% combined kill rate) |
| Evolved (cycle 1) | 4 |
| Selected for Quality Gate | 3 |
| **Passed Quality Gate** | **1 (CONDITIONAL PASS)** |
| Overall attrition | 93.3% (15 → 1) |
| Claim-level errors caught | 4 (C2-2 HMGB1 entry, C2-4 PqsR ring, E-H8 cryo-EM structure, C2-1 TRIM25 direction) |

## Key Discovery During Pipeline

**2025 Nature Communications paper (Li et al.)**: P. aeruginosa PQS induces macrophage ferroptosis via CNMT-TFR1 methylation. This means the QS→ferroptosis direction is ALREADY BEING EXPLORED. The ferroptosis→QS direction remains genuinely unexplored.

## Final Hypothesis

### C2-3: Pyocyanin Mitochondrial Redox Cycling Initiates Ferroptosis via CoQ10H2 Depletion
- **Composite Score**: 7.90 | **Confidence**: 5/10 | **Groundedness**: 82% (HIGH)
- **Novelty**: WEB-VERIFIED NOVEL (March 2026) — no published paper connects pyocyanin to ferroptosis
- **Bridge**: Pyocyanin's electrochemical potential matches CoQ10H2/CoQ10 couple → accepts electrons → depletes DHODH substrate → mitochondrial lipid peroxidation
- **Key prediction**: Ferrostatin-1 rescues pyocyanin-induced death in HBE cells; DHODH overexpression partially protects; brequinar + sub-lethal pyocyanin synergize
- **Counter-evidence**: Muller 2016 (renal cells, ferroptosis inhibitors did not protect — but cell type differs)
- **Effort**: 2-3 months, ~$15-25K, standard cell biology lab

## v5.4 Validation Effectiveness

The new claim-level verification caught errors that previous pipeline versions would have missed:

| Caught by | Error | Hypothesis |
|-----------|-------|-----------|
| Critic v9 | HMGB1 cannot enter bacteria (25 kDa, no transport) | C2-2 → KILLED |
| Critic v9 | PqsR requires aromatic ring for Tyr258 stacking | C2-4 → KILLED |
| QG rubric 10 | SLC7A11 "hydrophobic groove" not in cryo-EM structure | E-H8 → FAILED |
| QG rubric 10 | C2-7 trivially deducible from combining two existing papers | C2-7 → FAILED |
| Critic v9 | TRIM25 is ISG not NF-kB target (direction reversed) | C2-1 → KILLED |

## Limitations

- **Literature context was parametric-only** (Literature Scout MCP failed again)
- **Pipeline executed manually** (orchestrator sub-agent nesting limit)
- **C2-3 has cell-type counter-evidence** that needs resolution

## Cross-Model Validation Recommendations

1. Run `/export gpt` → validate C2-3's DHODH mechanism with GPT-5.4 Pro
2. Key questions for cross-validation:
   - Is pyocyanin's redox potential truly close enough to CoQ10H2/CoQ10 to accept electrons?
   - What is the expected IC50 for ferroptosis in HBE cells?
   - Why did Muller 2016 not see ferroptosis in renal cells?

## Remaining Unexplored Targets

1. **Circadian phase-separation × neurodegeneration** (S1, PARTIALLY EXPLORED, 7/10)
2. **Acoustic mechanotransduction × tumor immune reprogramming** (S1, PARTIALLY EXPLORED, 6/10)
3. **Mitochondrial cristae dynamics × synaptic plasticity** (S2, PARTIALLY EXPLORED, 7/10)
